Logo image of PRA

PROASSURANCE CORP (PRA) Stock Fundamental Analysis

USA - NYSE:PRA - US74267C1062 - Common Stock

24.005 USD
+0 (+0.02%)
Last: 10/16/2025, 1:34:53 PM
Fundamental Rating

2

PRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 145 industry peers in the Insurance industry. Both the profitability and financial health of PRA have multiple concerns. PRA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PRA had positive earnings in the past year.
In the past year PRA has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: PRA reported negative net income in multiple years.
In multiple years PRA reported negative operating cash flow during the last 5 years.
PRA Yearly Net Income VS EBIT VS OCF VS FCFPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

PRA has a worse Return On Assets (0.89%) than 62.07% of its industry peers.
PRA's Return On Equity of 3.82% is on the low side compared to the rest of the industry. PRA is outperformed by 79.31% of its industry peers.
PRA's Return On Invested Capital of 1.04% is on the low side compared to the rest of the industry. PRA is outperformed by 60.69% of its industry peers.
PRA had an Average Return On Invested Capital over the past 3 years of 0.50%. This is below the industry average of 4.40%.
The last Return On Invested Capital (1.04%) for PRA is above the 3 year average (0.50%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.89%
ROE 3.82%
ROIC 1.04%
ROA(3y)0.08%
ROA(5y)-0.24%
ROE(3y)0.29%
ROE(5y)-0.41%
ROIC(3y)0.5%
ROIC(5y)N/A
PRA Yearly ROA, ROE, ROICPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 4.39%, PRA is not doing good in the industry: 66.21% of the companies in the same industry are doing better.
PRA's Profit Margin has improved in the last couple of years.
PRA's Operating Margin of 6.11% is on the low side compared to the rest of the industry. PRA is outperformed by 73.10% of its industry peers.
PRA's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.11%
PM (TTM) 4.39%
GM N/A
OM growth 3Y13.27%
OM growth 5Y78.9%
PM growth 3Y-29.65%
PM growth 5Y116.12%
GM growth 3YN/A
GM growth 5YN/A
PRA Yearly Profit, Operating, Gross MarginsPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRA is destroying value.
The number of shares outstanding for PRA has been increased compared to 1 year ago.
The number of shares outstanding for PRA has been reduced compared to 5 years ago.
The debt/assets ratio for PRA is higher compared to a year ago.
PRA Yearly Shares OutstandingPRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PRA Yearly Total Debt VS Total AssetsPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

A Debt/Equity ratio of 0.33 indicates that PRA is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.33, PRA perfoms like the industry average, outperforming 42.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.14
WACC7.63%
PRA Yearly LT Debt VS Equity VS FCFPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
PRA Yearly Current Assets VS Current LiabilitesPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 610.53% over the past year.
Measured over the past years, PRA shows a very strong growth in Earnings Per Share. The EPS has been growing by 119.92% on average per year.
PRA shows a decrease in Revenue. In the last year, the revenue decreased by -2.62%.
Measured over the past years, PRA shows a small growth in Revenue. The Revenue has been growing by 2.27% on average per year.
EPS 1Y (TTM)610.53%
EPS 3Y-10.31%
EPS 5Y119.92%
EPS Q2Q%126.09%
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y1.68%
Revenue growth 5Y2.27%
Sales Q2Q%-3.12%

3.2 Future

The Earnings Per Share is expected to grow by 10.52% on average over the next years. This is quite good.
Based on estimates for the next years, PRA will show a decrease in Revenue. The Revenue will decrease by -0.50% on average per year.
EPS Next Y17.8%
EPS Next 2Y4.24%
EPS Next 3Y10.52%
EPS Next 5YN/A
Revenue Next Year-0.56%
Revenue Next 2Y-0.47%
Revenue Next 3Y-0.5%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PRA Yearly Revenue VS EstimatesPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
PRA Yearly EPS VS EstimatesPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.78, PRA is valued on the expensive side.
65.52% of the companies in the same industry are cheaper than PRA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.53. PRA is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 21.88, PRA is valued on the expensive side.
Based on the Price/Forward Earnings ratio, PRA is valued a bit more expensive than 74.48% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.04, PRA is valued at the same level.
Industry RankSector Rank
PE 17.78
Fwd PE 21.88
PRA Price Earnings VS Forward Price EarningsPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PRA is valued a bit more expensive than the industry average as 66.21% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.42
PRA Per share dataPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)1
PEG (5Y)0.15
EPS Next 2Y4.24%
EPS Next 3Y10.52%

3

5. Dividend

5.1 Amount

PRA has a Yearly Dividend Yield of 1.55%.
Compared to an average industry Dividend Yield of 3.54, PRA has a dividend in line with its industry peers.
PRA's Dividend Yield is slightly below the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

PRA has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PRA Yearly Dividends per sharePRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y4.24%
EPS Next 3Y10.52%
PRA Yearly Income VS Free CF VS DividendPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

PROASSURANCE CORP

NYSE:PRA (10/16/2025, 1:34:53 PM)

24.005

+0 (+0.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners91.14%
Inst Owner Change-0.01%
Ins Owners1.28%
Ins Owner Change3.77%
Market Cap1.23B
Analysts48.33
Price Target23.12 (-3.69%)
Short Float %11.58%
Short Ratio12.77
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)55.31%
Min EPS beat(2)-34.55%
Max EPS beat(2)145.17%
EPS beat(4)3
Avg EPS beat(4)89.79%
Min EPS beat(4)-34.55%
Max EPS beat(4)145.17%
EPS beat(8)5
Avg EPS beat(8)22.31%
EPS beat(12)6
Avg EPS beat(12)-10.39%
EPS beat(16)9
Avg EPS beat(16)20.44%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.8%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-3.93%
Revenue beat(12)2
Avg Revenue beat(12)-1.67%
Revenue beat(16)4
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)1.13%
EPS NQ rev (3m)-4.59%
EPS NY rev (1m)-1.05%
EPS NY rev (3m)35.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.63%
Valuation
Industry RankSector Rank
PE 17.78
Fwd PE 21.88
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 1.01
EV/EBITDA 19.42
EPS(TTM)1.35
EY5.62%
EPS(NY)1.1
Fwd EY4.57%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS21.58
BVpS24.81
TBVpS23.7
PEG (NY)1
PEG (5Y)0.15
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 3.82%
ROCE 1.24%
ROIC 1.04%
ROICexc 1.04%
ROICexgc 1.17%
OM 6.11%
PM (TTM) 4.39%
GM N/A
FCFM N/A
ROA(3y)0.08%
ROA(5y)-0.24%
ROE(3y)0.29%
ROE(5y)-0.41%
ROIC(3y)0.5%
ROIC(5y)N/A
ROICexc(3y)0.51%
ROICexc(5y)N/A
ROICexgc(3y)0.58%
ROICexgc(5y)N/A
ROCE(3y)0.6%
ROCE(5y)N/A
ROICexcg growth 3Y18.48%
ROICexcg growth 5Y73.91%
ROICexc growth 3Y18.73%
ROICexc growth 5Y76.59%
OM growth 3Y13.27%
OM growth 5Y78.9%
PM growth 3Y-29.65%
PM growth 5Y116.12%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 5.08
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.63%
ROIC/WACC0.14
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)610.53%
EPS 3Y-10.31%
EPS 5Y119.92%
EPS Q2Q%126.09%
EPS Next Y17.8%
EPS Next 2Y4.24%
EPS Next 3Y10.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y1.68%
Revenue growth 5Y2.27%
Sales Q2Q%-3.12%
Revenue Next Year-0.56%
Revenue Next 2Y-0.47%
Revenue Next 3Y-0.5%
Revenue Next 5YN/A
EBIT growth 1Y79.29%
EBIT growth 3Y15.18%
EBIT growth 5Y82.96%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.58%
OCF growth 3YN/A
OCF growth 5YN/A